![Johnson & Johnson scores an FDA first with nod for twice-yearly schizophrenia drug Invega Hafyera | Fierce Pharma Johnson & Johnson scores an FDA first with nod for twice-yearly schizophrenia drug Invega Hafyera | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1630434478/JNJIOffice3.jpg/JNJIOffice3.jpg?VersionId=nurdJ1vRC3EwUeHXMxrqSQwT9l6XtGwu)
Johnson & Johnson scores an FDA first with nod for twice-yearly schizophrenia drug Invega Hafyera | Fierce Pharma
GitHub - gsh199449/table-summ: BioGen: Generating Biography Summary under Table Guidance on Wikipedia
![Biogen's Double-WTF Moment, After Trading Halt All Day Friday: The Elusive Alzheimer's Money | Wolf Street Biogen's Double-WTF Moment, After Trading Halt All Day Friday: The Elusive Alzheimer's Money | Wolf Street](https://wolfstreet.com/wp-content/uploads/2020/11/US-Biogen-2020-11-09.png)
Biogen's Double-WTF Moment, After Trading Halt All Day Friday: The Elusive Alzheimer's Money | Wolf Street
![Three questions to Johanna Friedl-Naderer – President Europe, Canada & Partner Markets, Biogen - Interpharma Three questions to Johanna Friedl-Naderer – President Europe, Canada & Partner Markets, Biogen - Interpharma](https://www.interpharma.ch/wp-content/uploads/2020/06/Johanna-Naderer.jpg)
Three questions to Johanna Friedl-Naderer – President Europe, Canada & Partner Markets, Biogen - Interpharma
![Underline | Dissecting Generation Modes for Abstractive Summarization Models via Ablation and Attribution Underline | Dissecting Generation Modes for Abstractive Summarization Models via Ablation and Attribution](https://assets.underline.io/lecture/26510/poster/ec4633cc1b4f3d29577f3837d58b7993.jpg)